229 related articles for article (PubMed ID: 28135684)
1. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro.
Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M
Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684
[TBL] [Abstract][Full Text] [Related]
2. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
[TBL] [Abstract][Full Text] [Related]
4. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
[TBL] [Abstract][Full Text] [Related]
5. Whole-Genome DNA Methylation Analyses Revealed Epigenetic Instability in Tumorigenic Human iPS Cell-Derived Neural Stem/Progenitor Cells.
Iida T; Iwanami A; Sanosaka T; Kohyama J; Miyoshi H; Nagoshi N; Kashiwagi R; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cells; 2017 May; 35(5):1316-1327. PubMed ID: 28142229
[TBL] [Abstract][Full Text] [Related]
6. Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro.
Liu J; Götherström C; Forsberg M; Samuelsson EB; Wu J; Calzarossa C; Hovatta O; Sundström E; Åkesson E
Stem Cell Res; 2013 May; 10(3):325-37. PubMed ID: 23416350
[TBL] [Abstract][Full Text] [Related]
7. Safe and efficient method for cryopreservation of human induced pluripotent stem cell-derived neural stem and progenitor cells by a programmed freezer with a magnetic field.
Nishiyama Y; Iwanami A; Kohyama J; Itakura G; Kawabata S; Sugai K; Nishimura S; Kashiwagi R; Yasutake K; Isoda M; Matsumoto M; Nakamura M; Okano H
Neurosci Res; 2016 Jun; 107():20-9. PubMed ID: 26804710
[TBL] [Abstract][Full Text] [Related]
8. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
[TBL] [Abstract][Full Text] [Related]
9. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives.
Chen HF; Yu CY; Chen MJ; Chou SH; Chiang MS; Chou WH; Ko BS; Huang HP; Kuo HC; Ho HN
Cell Transplant; 2015; 24(5):845-64. PubMed ID: 24144439
[TBL] [Abstract][Full Text] [Related]
10. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
[TBL] [Abstract][Full Text] [Related]
11. Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells.
Liu P; Chen S; Li X; Qin L; Huang K; Wang L; Huang W; Li S; Jia B; Zhong M; Pan G; Cai J; Pei D
PLoS One; 2013; 8(7):e69617. PubMed ID: 23922758
[TBL] [Abstract][Full Text] [Related]
12. Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells.
Itakura G; Ozaki M; Nagoshi N; Kawabata S; Nishiyama Y; Sugai K; Iida T; Kashiwagi R; Ookubo T; Yastake K; Matsubayashi K; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
Sci Rep; 2017 Oct; 7(1):12996. PubMed ID: 29021610
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.
Iwai H; Shimada H; Nishimura S; Kobayashi Y; Itakura G; Hori K; Hikishima K; Ebise H; Negishi N; Shibata S; Habu S; Toyama Y; Nakamura M; Okano H
Stem Cells Transl Med; 2015 Jul; 4(7):708-19. PubMed ID: 26019226
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation.
Isoda M; Sanosaka T; Tomooka R; Mabuchi Y; Shinozaki M; Andoh-Noda T; Banno S; Mizota N; Yamaguchi R; Okano H; Kohyama J
Commun Biol; 2023 Jun; 6(1):611. PubMed ID: 37286713
[TBL] [Abstract][Full Text] [Related]
15. Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation.
Souidi N; Stolk M; Rudeck J; Strunk D; Schallmoser K; Volk HD; Seifert M
Stem Cells; 2017 May; 35(5):1233-1245. PubMed ID: 28100035
[TBL] [Abstract][Full Text] [Related]
16. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
[TBL] [Abstract][Full Text] [Related]
17. Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing.
Schmitt J; Eckardt S; Schlegel PG; Sirén AL; Bruttel VS; McLaughlin KJ; Wischhusen J; Müller AM
Mol Med; 2015 Mar; 21(1):185-96. PubMed ID: 25811991
[TBL] [Abstract][Full Text] [Related]
18. Limited Immunogenicity of Human Induced Pluripotent Stem Cell-Derived Cartilages.
Kimura T; Yamashita A; Ozono K; Tsumaki N
Tissue Eng Part A; 2016 Dec; 22(23-24):1367-1375. PubMed ID: 27762664
[TBL] [Abstract][Full Text] [Related]
19. Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions.
Isoda M; Kohyama J; Iwanami A; Sanosaka T; Sugai K; Yamaguchi R; Matsumoto T; Nakamura M; Okano H
Neurosci Res; 2016 Sep; 110():18-28. PubMed ID: 27083781
[TBL] [Abstract][Full Text] [Related]
20. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice.
Sun YQ; Zhang Y; Li X; Deng MX; Gao WX; Yao Y; Chiu SM; Liang X; Gao F; Chan CW; Tse HF; Shi J; Fu QL; Lian Q
Stem Cells; 2015 Dec; 33(12):3452-67. PubMed ID: 26175298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
